IDEAYA Biosciences, Inc. (IDYA): Price and Financial Metrics


IDEAYA Biosciences, Inc. (IDYA)

Today's Latest Price: $13.73 USD

0.39 (2.92%)

Updated Jul 2 4:00pm

Add IDYA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

IDYA Daily Price Range
IDYA 52-Week Price Range

IDYA Stock Price Chart Technical Analysis Charts


IDYA Price/Volume Stats

Current price $13.73 52-week high $19.97
Prev. close $13.34 52-week low $2.95
Day low $13.08 Volume 466,489
Day high $14.19 Avg. volume 144,878
50-day MA $9.19 Dividend yield N/A
200-day MA $7.52 Market Cap 280.08M

IDEAYA Biosciences, Inc. (IDYA) Company Bio


IDEAYA Biosciences, Inc. develops cancer therapeutics. It is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company operates and manages its business as one operating and reportable segment, which is the business of research and development for oncology-focused precision medicine. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.


IDYA Latest News Stream


Event/TimeNews Detail
Loading, please wait...

IDYA Latest Social Stream


Loading social stream, please wait...

View Full IDYA Social Stream

Latest IDYA News From Around the Web

Below are the latest news stories about IDEAYA Biosciences Inc that investors may wish to consider to help them evaluate IDYA as an investment opportunity.

IDEAYA Appoints Garret Hampton, Ph.D., to the Board of Directors, an Industry Leader in Precision Medicine Oncology and Diagnostics

IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics based on Synthetic Lethality, announced the appointment of Garret Hampton, Ph.D., to its Board of Directors.

Yahoo | June 30, 2020

Ideaya Biosciences Is Risky But Also Compelling

A high-profile partnership and a promising pipeline of oncology-focused treatments suggest favorable reward-versus-risk in IDYA stock.

InvestorPlace | June 23, 2020

Repare and Forma Shares Gobbled Up in IPO

Both companies boosted price and number of shares in their offerings Continue reading...

Yahoo | June 22, 2020

Ideaya prices equity offering at $15

IDEAYA Biosciences (IDYA) has priced its public offering of ~6.7M common shares at $15.00/share, for expected gross proceeds of $100M.Underwriters' over-allotment is an additional 1M shares. Net proceeds will be used to fund preclinical and clinical development of product candidates and ongoing clinical trials, research and development activities and working capital...

Seeking Alpha | June 18, 2020

IDEAYA Announces Pricing of Public Offering of Common Stock

IDEAYA Biosciences, Inc. (Nasdaq: IDYA) today announced the pricing of an underwritten public offering of 6,666,667 shares of its common stock at a public offering price of $15.00 per share, before underwriting discounts and commissions. In addition, IDEAYA has granted the underwriters a 30-day option to purchase up to an additional 1,000,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by IDEAYA, are expected to be $100.0 million excluding any exercise of the underwriters' option to purchase additional shares. The offering is expected to close on or about June 22, 2020, subject to the satisfaction of c...

Yahoo | June 18, 2020

Read More 'IDYA' Stories Here

IDYA Price Returns

1-mo 70.77%
3-mo 259.42%
6-mo 53.41%
1-year 71.41%
3-year N/A
5-year N/A
YTD 83.07%
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7672 seconds.